Advanced Cyclotron Systems, Inc. (ACSI) is a company based in Richmond, British Columbia, Canada that supplies and services cyclotrons predominantly used for the production of medical isotopes by hospitals for nuclear medicine. The company was a spin-off of the research program at TRIUMF.[1] The machines are used for the production of isotopes used in Positron emission tomography (PET), Single-photon emission computed tomography (SPECT) or production of technetium-99 for molecular imaging.[2] ACSI controls approximately half the world market for such machines,[2]
![]() | |
Company type | Private Company |
---|---|
Industry | Particle Accelerators |
Headquarters | , |
Key people | Richard Eppich CEO |
Products | Cyclotron |
Parent | Ebco Industries |
Website | advancedcyclotron.com |
Four models of cyclotrons are offered:
- TR-19 (14 MeV to 19 MeV) variable energy negative ion cyclotrons
- TR-24 (15 to 24 MeV) high current cyclotron used for the production of PET and SPECT isotopes; including one machine installed at the Université de Sherbrooke,[citation needed]
- TR-FLEX (18 MeV up to 30 MeV) high current cyclotron used for PET and SPECT isotopes.[citation needed]
- TR-30 (15 MeV to 30 MeV) high current cyclotron used for SPECT isotopes.
References and footnotes
edit- ^ "Vancouver could become the Silicon Valley of medical isotopes". Vancouver Sun. postmedia. 2001-11-24. Retrieved 2012-08-13.
- ^ a b "Rise of the Cyclotron". BC Business. Retrieved 2012-08-13.